You have probably heard the expression “medicine is not an exact science” and not considered what they meant until faced with a severe illness or a crisis like COVID-19. Today, we sit by and watch top doctors and researchers scramble for cures, treatments, and adequate testing to help put society back on its proverbial feet. The headlines adequately reflect the adage as we read about flawed antibody tests and false-negative COVID tests, which taint our understanding of the epidemic. Research is seldom a linear process, nor is the practice of medicine. Our bodies are composed of interdependent systems with complex structures rooted in our DNA and genotypes.
When the most vulnerable children rely on your researchers to find the answers that will lead them to a longer life, the pressure is always on. There is a palpable sense of urgency that beats with each new heartbeat knowing that today a heart transplant is not a cure, but a bridge to life, lasting on average 17 years. To combat this harsh reality, Enduring Hearts actively funds the brightest scientists from around the world who actively seek to find the cause and treatment of organ rejection, the primary driver of transplant failure.
We believe that pediatric heart transplants should last forever, and that no child should have an expiration date on their second chance at life. That is why we exist to give extraordinary heart transplant children and their families the best chance at living a beautifully ordinary childhood.
A HEART TRANSPLANT IS NOT A CURE, BUT A BRIDGE TO LIFE…
Atlanta-based Enduring Hearts launched in 2013 with a mission to fund research that increases the longevity of pediatric heart transplants, improve the quality of life for children living with a new heart and eliminate pediatric heart diseases that may lead to a transplant.